123 related articles for article (PubMed ID: 18331824)
1. Short interfering RNA directed against TWIST, a novel zinc finger transcription factor, increases A549 cell sensitivity to cisplatin via MAPK/mitochondrial pathway.
Zhuo WL; Wang Y; Zhuo XL; Zhang YS; Chen ZT
Biochem Biophys Res Commun; 2008 May; 369(4):1098-102. PubMed ID: 18331824
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of Snail, a novel zinc finger transcription factor, via RNA interference increases A549 cell sensitivity to cisplatin via JNK/mitochondrial pathway.
Zhuo W; Wang Y; Zhuo X; Zhang Y; Ao X; Chen Z
Lung Cancer; 2008 Oct; 62(1):8-14. PubMed ID: 18372076
[TBL] [Abstract][Full Text] [Related]
3. Twist promotes tumor cell growth through YB-1 expression.
Shiota M; Izumi H; Onitsuka T; Miyamoto N; Kashiwagi E; Kidani A; Yokomizo A; Naito S; Kohno K
Cancer Res; 2008 Jan; 68(1):98-105. PubMed ID: 18172301
[TBL] [Abstract][Full Text] [Related]
4. miR-23a promotes cisplatin chemoresistance and protects against cisplatin-induced apoptosis in tongue squamous cell carcinoma cells through Twist.
Peng F; Zhang H; Du Y; Tan P
Oncol Rep; 2015 Feb; 33(2):942-50. PubMed ID: 25501015
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of TWIST enhances the cytotoxicity of chemotherapeutic drugs in doxorubicin-resistant HepG2 cells by suppressing MDR1 and EMT.
Li R; Wu C; Liang H; Zhao Y; Lin C; Zhang X; Ye C
Int J Oncol; 2018 Oct; 53(4):1763-1773. PubMed ID: 30066890
[TBL] [Abstract][Full Text] [Related]
6. Twist promotes invasion and cisplatin resistance in pancreatic cancer cells through growth differentiation factor 15.
Ji H; Lu HW; Li YM; Lu L; Wang JL; Zhang YF; Shang H
Mol Med Rep; 2015 Sep; 12(3):3841-3848. PubMed ID: 26018318
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the response of prostate cancer cell lines to cisplatin treatment using small interfering RNA.
Parra E; Ferreira J
Oncol Rep; 2013 Oct; 30(4):1936-42. PubMed ID: 23900581
[TBL] [Abstract][Full Text] [Related]
8. Combination of Niraparib, Cisplatin and Twist Knockdown in Cisplatin-Resistant Ovarian Cancer Cells Potentially Enhances Synthetic Lethality through ER-Stress Mediated Mitochondrial Apoptosis Pathway.
Bahar E; Kim JY; Kim DC; Kim HS; Yoon H
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920140
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
[TBL] [Abstract][Full Text] [Related]
10. The DNA Damage Transducer RNF8 Facilitates Cancer Chemoresistance and Progression through Twist Activation.
Lee HJ; Li CF; Ruan D; Powers S; Thompson PA; Frohman MA; Chan CH
Mol Cell; 2016 Sep; 63(6):1021-33. PubMed ID: 27618486
[TBL] [Abstract][Full Text] [Related]
11. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.
Chung LY; Tang SJ; Sun GH; Chou TY; Yeh TS; Yu SL; Sun KH
Clin Cancer Res; 2012 Aug; 18(15):4037-47. PubMed ID: 22696230
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of MUTYH contributes to cisplatin‑resistance of esophageal squamous cell carcinoma cells by promoting Twist‑mediated EMT.
Guo Y; Jia Y; Wang S; Liu N; Gao D; Zhang L; Lin Z; Wang S; Kong F; Peng C; Liu Y
Oncol Rep; 2019 Dec; 42(6):2716-2727. PubMed ID: 31578574
[TBL] [Abstract][Full Text] [Related]
13. Short hairpin RNA targeting Twist1 suppresses cell proliferation and improves chemosensitivity to cisplatin in HeLa human cervical cancer cells.
Zhu K; Chen L; Han X; Wang J; Wang J
Oncol Rep; 2012 Apr; 27(4):1027-34. PubMed ID: 22245869
[TBL] [Abstract][Full Text] [Related]
14. The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancers.
Wallerand H; Robert G; Pasticier G; Ravaud A; Ballanger P; Reiter RE; Ferrière JM
Urol Oncol; 2010; 28(5):473-9. PubMed ID: 19272800
[TBL] [Abstract][Full Text] [Related]
15. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel.
Cheng GZ; Chan J; Wang Q; Zhang W; Sun CD; Wang LH
Cancer Res; 2007 Mar; 67(5):1979-87. PubMed ID: 17332325
[TBL] [Abstract][Full Text] [Related]
16. Pellino-1 confers chemoresistance in lung cancer cells by upregulating cIAP2 through Lys63-mediated polyubiquitination.
Jeon YK; Kim CK; Koh J; Chung DH; Ha GH
Oncotarget; 2016 Jul; 7(27):41811-41824. PubMed ID: 27248820
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of Twist-1 by NF-kappaB blocks cytotoxicity induced by chemotherapeutic drugs.
Pham CG; Bubici C; Zazzeroni F; Knabb JR; Papa S; Kuntzen C; Franzoso G
Mol Cell Biol; 2007 Jun; 27(11):3920-35. PubMed ID: 17403902
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling in TWIST-depleted gastric cancer cells.
Feng MY; Wang K; Shi QT; Yu XW; Geng JS
Anat Rec (Hoboken); 2009 Feb; 292(2):262-70. PubMed ID: 19051271
[TBL] [Abstract][Full Text] [Related]
19. Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer.
Homma S; Ishii Y; Morishima Y; Yamadori T; Matsuno Y; Haraguchi N; Kikuchi N; Satoh H; Sakamoto T; Hizawa N; Itoh K; Yamamoto M
Clin Cancer Res; 2009 May; 15(10):3423-32. PubMed ID: 19417020
[TBL] [Abstract][Full Text] [Related]
20. Reversing effect and mechanism of soluble resistance-related calcium-binding protein on multidrug resistance in human lung cancer A549/DDP cells.
Gao Y; Li W; Liu X; Gao F; Zhao X
Mol Med Rep; 2015 Mar; 11(3):2118-24. PubMed ID: 25394367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]